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Results of endovascular treatment for patients with
nutcracker syndrome
Xiaobai Wang, MD, Yan Zhang, MD, Chengzhi Li, MD, and Hong Zhang, MD, Guangzhou, China
Objective: To retrospectively assess the therapeutic value of endovascular stenting for treatment of the nutcracker
syndrome (NCS) in long-term follow-up and to explore the selection of the size of stents in Chinese patients with NCS.
Methods: From January 2004 to August 2010, 30 patients (two women and 28 men) between 13 and 32 years old (mean,
18.2) who were diagnosed with NCSwere admitted for endovascular treatment. Each patient received one self-expanding
metallic stent (14-mm diameter, 60-mm long) in the compressed portion of the left renal vein during the operation, and
three patients with severe left-sided varicoceles received left gonadal vein embolization. The postoperative follow-up was
12 to 80 months (median, 36.0 months).
Results: The diameters at the ostium of left renal vein measured by the ultrasonic examination before treatment were
11.8 1.8mm. Technical success of operation was achieved in all patients. No perioperative complications occurred. Two
cases of stent migration were found at 12 months: both stents prolapsed into the inferior vena cava, with uneventful
follow-up (49 and 56 months, respectively). At 1-month follow-up, patients improved, including two patients who had
persistent but less microscopic hematuria than before treatment. The clinical symptoms related to NCS almost
disappeared at 3 months after the treatment. All stents were patent at the duplex scan examination, without restenosis,
and no secondary recurrence of the symptoms occurred at the end of the follow-up.
Conclusions: Endovascular treatment is a safe, effective, and very minimally invasive technique that provides good
long-term patency rates for patients with NCS, and under the premise morphologic measurements, 14-mm-diameter,
60-mm-long self-expanding stents should be first considered for Chinese patients with NCS. (J Vasc Surg 2012;56:
142-8.)
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rNutcracker syndrome (NCS) is caused by compression
of the left renal vein (LRV) between the aorta and the
superior mesenteric artery.1-3 This phenomenon results in
consecutively increased LRV pressure, which promotes the
development of varices of the renal pelvis and ureter with
associated hematuria. Other possible symptoms include
left-sided varicocele, left flank/abdominal pain, orthostatic
proteinuria, pelvic congestion, and chronic fatigue.4-7
Although NCS is relatively rare in the clinical work,
more and more doctors have focused on this kind of
disease. Mild and tolerable symptoms should be treated
conservatively. However, patients with symptoms such as
severe flank or abdominal pain, serious left-sided varicocele
affecting breeding, and recurrent gross hematuria, which
have seriously affected their daily life and work, may need
invasive treatment.8,9 Surgical techniques mainly include
reanastomosis of the LRV into the inferior vena cava and
kidney autografting, which both aim at lowering the in-
trarenal venous pressure by removing the renal vein outflow
obstruction.
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142For this purpose, interventional, as well as open, tech-
iques have been described. Although the use of stents
ithin the venous circulation bears potential risks, such as
n-stent stenosis and occlusion, experience gained in treat-
ng superior vena caval syndrome and Budd-Chiari syn-
rome,10 which have achieved satisfactory results, were the
asis of endovascular stent placement for patients with
CS. However, so far, the experience of endovascular
reatment in NCS is seldom reported in case reports, and
esearch with long-term follow-up is reported still less. The
oal of this study is to report our experience and to analyze
he long-term results of endovascular stenting for patients
ith NCS.
ETHODS
Eligibility. From January 2004 to August 2010, 30
atients (twowomen and 28men) between 13 and 32 years
ld (mean, 18.2), who had been diagnosed with NCS in
ur department and experienced endovascular treatment,
ere selected for this study. Their leading symptoms were
icrohematuria in 21 and gross hematuria in seven; 26
ale patients had left-sided varicoceles and fertility was
ffected in four of them who were of reproductive age; 15
atients had left flank/abdominal pain, which was intoler-
ble in four of them when admitted. The key criteria for
onfirmation of the NCS were bleeding from the left ure-
eral orifice, visible entrapment of the LRV between the
orta and superior mesenteric artery on diagnostic imaging,
nd an elevated pressure gradient between the prestenotic
enal vein and the inferior vena cava. The criteria of duplex
can and computed tomography (CT) scan for NCS is
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Volume 56, Number 1 Wang et al 143stenosis of the LRV with proximal distention and the
presence of collateral pathways.11
All patients underwent routine laboratory investiga-
tions, urine cytology, and color Doppler ultrasonography
in order to make a final diagnosis. In addition, CT was
performed in 11 patients and magnetic resonance imaging
was performed in six patients to make a comprehensive
assessment of the compressed LRV. Finally, LRV phlebog-
raphy with renocaval pressure gradient determination was
performed before treatment (normal 1 mm Hg). Of the
30 patients, 24 were followed up conservatively with peri-
odic urinalysis and complete blood counts for more than 2
years without improvement before the treatment was
started, and in five patients, the condition was aggravated
during the surveillance. In the other six patients, four cases
were treated for intolerable left flank/abdominal pain and
two cases were admitted for sterility caused by the left-sided
varicocele.
Institutional review. The experimental protocol and
informed consent in this study, which follows the principles
outlined in the Declaration of Helsinki, were approved by
the institutional review board of Jinan University.
Procedures. All procedures were performed in the
operating room. Under local anesthesia, the right femoral
vein was punctured, and a 5F sheath was introduced.
Phlebography was performed in the inferior vena cava with
a 5F pigtail angiographic catheter (Cook, Bloomington,
Ind) and in the LRV with a 5F cobra angiographic catheter
(Cook). The phlebography showed that all LRVs were
stenotic with a compression in the NCS patients (Fig 1),
and 26 patients had left-sided varicoceles (Fig 2, A and B).
Meanwhile, the renocaval pressure gradient was measured
in all cases to confirm the diagnosis. In three patients with
severe left-sided varicocele, selective catheterization of the
dilated left gonadal vein was performed with a 5F cobra
catheter, and metallic coil embolization (Cook) was per-
formed to the proximal left gonadal vein. Repeated venog-
raphy of the LRV showed occlusion of the gonadal vein
(Fig 2, C). Once NCS was confirmed, intravenous heparin
(80 UI/kg) was given in all cases. The 5F sheath was
replaced with an 8F sheath (Cordis; Johnson and Johnson,
Miami, Fla) through a 260-cm 0.035-inch guidewire
(Terumo, Tokyo, Japan) to accommodate the stent deliv-
ery system. Then, an 8F RDC guiding catheter (Cordis)
was inserted into the proximal LRV. According to the
vascular data measured by the software of a digital subtrac-
tion angiography machine (GE, Fairfield, Conn), a self-
expanding metallic stent (SMART control nitinol stent;
Cordis) was deployed in the stenotic portion of the LRV,
making sure that the distal end of the stent was deployed in
the first large branch of the LRV to achieve good fixation.
Finally, completion venography was performed within the
stent before the sheath was retrieved (Fig 2, D). All these
procedures were performed by one experienced interven-
tional radiologist in a single center. To prevent thrombosis,
all patients received low-molecular-weight heparin for 2
days after the treatment and were discharged on oral war-
farin for at least 6 months (median, 9 months). rFollow-up. Clinical examination and color Doppler
ltrasonography were scheduled at 1, 3, 6, and 12 months
nd then annually or if symptoms recurred. In-stent reste-
osis was defined as more than 50% inflow obstruction
morphologic) in the LRV stent.
Statistical analysis. All statistical calculations were per-
ormed with SPSS software, version 11.5 for PC (SPSS Inc,
hicago, Ill). Fisher exact test was performed to compare
he patients’ symptoms before and 3 months after the
reatment. A P value of .05 was chosen as the level of
ignificance. In sterile patients, rank sum test was used to
ompare the difference of sperm motility before and 3
onths after the treatment. A P value .1 was chosen as
he level of significance.
ESULTS
Short-term results. All patients met the key criteria
entioned in the eligibility section for making the diag-
osis of NCS. Ultrasonography, CT, and magnetic res-
nance imaging revealed entrapment of the LRV be-
ween the superior mesenteric artery and aorta clearly
Fig 3). The diameters at the ostium of LRV measured by
ltrasonic examination before treatment were 11.8  1.8
m. Themedian pressure gradient between the prestenotic
ig 1. Selective left renal phlebography demonstrating severe
tenosis of the pre-aortic segment of the left renal vein (LRV) with
compression in nutcracker syndrome (NCS) patients.enal vein and the inferior vena cava, measured during LRV
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July 2012144 Wang et alvenography, was 8.9 mmHg (4.3-16.2 mmHg). And, this
pressure gradient decreased to 2.1 mm Hg (1.4-4.8 mm
Hg) after the stent deployment. The pressure gradient
decreased in most patients; however, it was worth noting
that there was no significant change of pressure gradient in
one patient in this study after stenting.
Technical success was achieved in all patients, including
the three patients with left gonadal vein embolization. Each
patient received a 14-mm-diameter, 60-mm-long self-ex-
panding stent during the treatment in the present study.
No complication occurred during the treatment. However,
the distal end of one stent did not fit well in the first large
branch of the LRV in a patient, leading to later migration.
Results of long-term follow-up. The follow-up
range was 12 to 80 months (median, 36.0 months). At 1
month, all patients had improved, including two patients
who had persistent but less microscopic hematuria than
before treatment (the quantity of red blood cells in each
high-power field reduced in these two patients even under
Fig 2. Selective left renal phlebography in another nut
renal vein (LRV) with dye stagnation and large colla
massive reflux in the left gonadic vein (arrow) (B). Me
gonadic vein in the patient and repeated venography of
massive reflux disappeared (C). Completion venograph
the stenosis of the LRV was relieved. To achieve good fi
first large branch of the LRV. Therefore, the left end o
of the remaining portion of the stent (D).warfarin treatment). The clinical symptoms related to NCS sot only get fewer in number but also get lesser in degree at
he 3-month follow-up. The data from the 30 patients
ndergoing interventional treatment are summarized in
ables I and II. There was significant difference between
he symptoms before and 3 months after the operation
P  .001). In sterile patients, sperm motility improved at
months after the treatment (Z  1.83; P  .07). Color
oppler ultrasonography was taken at 1, 3, 6, and 12
onths and then annually after the operation or if symp-
oms recurred (the median follow-up at the last duplex scan
as 36.0 months). During the follow-up, the color Dopp-
er ultrasonography showed the absence of residual stenosis
ith good flow in the LRV and all stents were patent. No
urther left gonadal vein reflux was observed in all 30
atients (even in those who did not have prior emboliza-
ion). Stent migration was observed in two patients without
ecurrence of the symptoms at 12 months after the opera-
ion and no stent reimplantation or surgery was needed
Fig 4). In these two displaced stents, one proximal end
er syndrome (NCS) patient showed stenosis of the left
pathways (left gonadic vein) (arrow) (A). There was
coil embolization was performed in the proximal left
RV showed the occlusion of the gonadal vein, and the
hin the stent before the sheath was retrieved, showing
n, the distal (left) end of the stent was deployed in the
stent appears to be stenosed at 50% of the diametercrack
teral
tallic
the L
y wit
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f thelightly protruded into the inferior vena cava, while most of
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HWilcoxon rank-sum test (a  0.1), Z  1.83, P  .07.
angiography and magnetic resonance angiography also showe
Fisher exact test (a  0.05).
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Volume 56, Number 1 Wang et al 145he other one migrated into the inferior vena cava with the
roximal end staying at the opposite wall of the inferior
ena cava and the distal end still staying at the stenotic
ortion of the LRV. Both patients are currently under close
urveillance and no adverse effect occurred after 49- and
6-month follow-up, respectively. No complications oc-
urred in the other 28 patients at the end of the follow-up
n this study.
ISCUSSION
Currently, traditional open surgery has achieved some
ood results in a series of research in the treatment of NCS.
CT) (C), and magnetic resonance imaging (D) revealed
een the superior mesenteric artery and aorta clearly. CT
d the dilatation of the LRV.
th nutcracker syndrome (NCS) 1 and 3 months after the
nth after treatment 3 months after treatment P value
8 2 .000
2 0 .000
0 0 .000Table II. Comparison of the sperm motility rate before
and 3 months after the operation in patients with
abnormal sperm
Patient number
Sperm motility rate
before treatment
(%)
Sperm motility rate
3 months after
treatment (%)
1 16.25 61.11
2 48.72 71.13
3 50.01 74.31
4 15.44 59.78Fig 3. Ultrasonography (A and B), computed tomography (
the entrapment of the left renal vein (LRV) (blue arrows) betwTable I. Improvements of clinical symptoms of the patients wi
operation
Before treatment 1 mo
Left-sided varicocele (n) 26
Hematuria/microscopic hematuria (n) 28
Flank/abdominal pain (n) 15owever, it is associated with higher surgical morbidity
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July 2012146 Wang et aland several complications, such as deep venous thrombosis,
retroperitoneal hematoma, paralytic ileus, and mechanical
ileus caused by intestinal adhesion.12,13
In recent years, endovascular stent placement has been
used more frequently as the therapy of choice in the treat-
ment of vascular lesions.14 Since the clinical applications of
endovascular stent placement have achieved satisfactory
results in the treatment of obstructive venous diseases such
as superior vena caval syndrome and Budd-Chiari syn-
drome in the past,15 some researchers have indicated that
endovascular stenting might become the first approach in
the management of patients with NCS in the future.16 The
present study reported 30 patients with NCS who had
endovascular treatment with a relatively long follow-up in a
single therapy center. The long-term results were reported
and the size of stent was analyzed.
Therapeutic effect evaluation. Of the 30 patients in
this study, 29 had a significant drop of the pressure gradient
between the LRV and the inferior vena cava. However, this
pressure gradient did not change in one patient after stent
implantation, which was the same result reported by Zhang
and Sharper.17,18 Therefore, we concluded that in spite of
all stents being in the right place, with the narrow portion
of the LRV well expanded, there was no change in the
venous pressure in some patients. Reasons were thought to
be that the LRV was hyperbaric for a long time in NCS
patients and the pressure drop needed a relatively long
period in some cases.
In 2007, Zhang et al19 reported stent implantation to
the LRV in 15 NCS patients. In their research, two cases
still had microscopic hematuria after the treatment. In
Sharper’s report, hematuria resolved in four patients and
was aggravated in one.18 Patients in this study underwent
clinical examination and color Doppler ultrasonography at
1, 3, 6, and 12 months and then annually or if symptoms
recurred during follow-up. At 1 month, all patients had
improved, including two patients who had persistent but
less microscopic hematuria than before treatment (similar
Fig 4. Compared with the plain abdominal radiograph i
migrated to the right at 12 months after the operation (to Zhang and Sharper’s research). The microscopic hema- Huria in these two patients resolved at 3 months without
urther treatment.
Stent migration was observed in two patients at 12
onths after the treatment. This complication was mainly
aused by the anatomy of the LRV and the size of the stent.
easons for stent migration in this study were thought to
e as follows: (1) The distance between the ostium and the
rst large branch of the LRVwas too long in one patient, so
hat the distal end of the stent could not fit well in the first
ranch of the LRV. (2) The high pressure within the LRV
ade the distal lumen dilated. Although the stent was
tabilized in the stenotic part of the LRV, it still could not
t well in the dilated lumen of the LRV. (3) A patient’s early
ctivity as well as friction between the pulsating aorta and
he stent may cause stent migration. Although two stents
igrated into the inferior vena cava in this study, early
esearchers had reported that migrated stents were left in
he inferior vena cava without adverse effect after long-term
ollow-up.11 Moreover, inferior vena cava filters, although
ainly inserted in cases of thrombotic events and in most
ases without heparin or warfarin therapy, have long-term
atency rates of 90% at 10 years,20 which further led us to
elieve that stents migrated into inferior vena cava would
ot cause any severe adverse effect.
The clinical symptoms related to NCS not only de-
reased in number but also in degree at the 3-month
ollow-up in this study, which was a good result. In addi-
ion, until the end of the follow-up of the present study, all
mplanted stents were patent, and there was no adverse
vent in the other 28 patients with NCS. Through long-
erm follow-up after stent implantation, this study ulti-
ately achieved satisfactory long-term results for patients
ith NCS, which provided a more extensive idea of the
reatment.
Selection of the size of stents in Chinese patients
ithNCS. One of themain technical end points is the size
f stent to use. In Segawa’s report,10 a 20-mm-diameter
tent was suggested for use in NCS patients. However,
iately after the operation (A), the stent was significantlymmedartung et al11 reported that the 20-mm-diameter cor-
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during balloon angioplasty. Chen et al21 described the LRV
stent that migrated into the right ventricle in two patients
with NCS, and they indicated that reasons for stent migra-
tion were anatomy of the LRV and the size of stents, too.
Therefore, to avoid stent migration, stent oversizing is
advisable. Also, they recommended to oversize the stent by
20% on the basis of the diameter of the LRV in the renal
hilum measured in the ultrasonic examination and mag-
netic resonance angiography. Hartung et al11 suggested
that the 16-mm-diameter, 60-mm-long stent should be
considered as the basis of sizing for LRV stenting. How-
ever, themorphologic measurements achieved from venog-
raphymust be considered first. In Chen’s latest research, 61
Chinese patients were treated endovascularly with 10-, 12-,
14-, or 16-mm-diameter stents.13 Migration occurred in
two patients with stent diameters of 10 mm and 12 mm,
respectively. Finally, they recommended using 14-mm
stents in our Asian patients. According to our own experi-
ence, compared with Westerners, our Asian patients are
smaller. Considering the advice of using oversized stents in
the endovascular treatment of NCS, we tentatively used
14-mm-diameter stents on the patients in this study, which
was similar to Chen’s report (actually the stents also corre-
sponded to the morphologic measurements achieved by
ultrasound before treatment in these patients). Finally, we
achieved a favorable long-term result.
As for the length selection of the stent, Segawa et al10
suggested that the stent should be 2 cm longer than the
stenosed or obstructed segment of the LRV, and Chen
advised to use 40-mm-long stents in our Asian patients in
his latest study. In our cases 60-mm-long stents, which
were longer than the stenotic segment of the LRV, were
used. On the one hand, the distal end of the longer stent
could be better stabilized in the first large branch of the LRV.
On the other hand, once migration occurred, the proximal
end of the longer stent would probably stay at the opposite
wall of the inferior vena cava with the distal end still staying
at the stenotic segment of the LRV. This would prevent the
stent migrating into the heart. What’s more, in Chen’s
research,13 hematuria recurred 15 months postoperatively
in one patient who received a 40-mm-long stent. This stent
moved to the left side of the LRV, causing the superior
mesenteric artery to compress the LRV again. In our opin-
ion, the 60-mm-long stent would probably prevent the
symptom relapse when migration occurred because the
distal/proximal end of the migrated longer stents could
still produce a therapeutic effect in the stenosed or ob-
structed segment of the LRV. Finally, the anatomy data of
the Chinese show that the mean length of the LRV in
Chinese is 6.47 cm, and the mean diameter at the ostium of
the LRV is 1.46 cm.22 These data were closer to the stent
size (14mm-6 cm) we have chosen in our study. Therefore,
we recommend that the 14-mm-diameter, 60-mm-long
stent should conform to our Chinese morphology and
anatomic measurements.
Segawa et al10 stated that balloon angioplasty is needed
before insertion of the stent. However, no balloon angio-lasty was performed in the patients with NCS of this study.
echnical success and good long-term results were finally
chieved at the end of the follow-up. Therefore, we pre-
umed that balloon angioplasty was not imperative in the
ndovascular treatment of NCS. This standpoint is in
greement with Chen’s.
Limitations of this study. SMART stent delivery sys-
ems could not go smoothly in the 6F RDC guiding
atheters, and the 7F RDC guiding catheters were out of
tock in the region of our hospital in our country. There-
ore, we used the 8F RDC guiding catheters and the 8F
heaths instead of 6F or 7F ones.
ONCLUSIONS
Endovascular treatment is a safe, effective, and very
inimally invasive technique that provides good long-term
atency rates for patients with NCS. However, further
xperience and follow-up are needed before accepting such
procedure for the superior choice of the treatment for
CS. In addition, under the premise of morphologic mea-
urements, 14-mm-diameter, 60-mm-long self-expanding
tents should be considered as the basis of sizing for LRV
tenting in Chinese patients with NCS.
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